UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003865
Receipt number R000004650
Scientific Title peginterferon plus ribavirin and glutamine therapy against chronic hepatitis C
Date of disclosure of the study information 2010/08/01
Last modified on 2023/07/14 09:17:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

peginterferon plus ribavirin and glutamine therapy against chronic hepatitis C

Acronym

IFN + glutamine therapy

Scientific Title

peginterferon plus ribavirin and glutamine therapy against chronic hepatitis C

Scientific Title:Acronym

IFN + glutamine therapy

Region

Japan


Condition

Condition

Chronic hepatitis C

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Efficacy of peginterferon plus ribavirin and glutamine therapy

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I,II


Assessment

Primary outcomes

Sustained virological response or non-response

Key secondary outcomes

Safety


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

peginterferon plus ribavirin and oral administration of glutamine

Interventions/Control_2

peginterferon plus ribavirin

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

genotype 1b and high viral load (greater than 5.0LogIU/mL)

Key exclusion criteria

liver cirrhosis
autoimmune hepatitis
primary biliary cirrhosis
malignancy
depression
drug abuse
pregnant or lactating woman

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshimichi Haruna

Organization

Osaka Prefectural General Medical Center

Division name

Department of Gastroenterology and Hepatology

Zip code


Address

3-1-56 Bandaihigashi, Sumiyoshiku, Osaka 558-8558

TEL

06-6692-1201

Email



Public contact

Name of contact person

1st name
Middle name
Last name Yoshimichi Haruna

Organization

Osaka Prefectural General Medical Center

Division name

Department of Gastroenterology and Hepatology

Zip code


Address


TEL


Homepage URL


Email

apple-123-grape@ab.auone-net.jp


Sponsor or person

Institute

Osaka Prefectural General Medical Center

Institute

Department

Personal name



Funding Source

Organization

Osaka Prefectural General Medical Center

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪府立急性期・総合医療センタ-(大阪府)


Other administrative information

Date of disclosure of the study information

2010 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2010 Year 05 Month 15 Day

Date of IRB

2010 Year 05 Month 15 Day

Anticipated trial start date

2010 Year 08 Month 01 Day

Last follow-up date

2020 Year 07 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2023 Year 07 Month 01 Day


Other

Other related information



Management information

Registered date

2010 Year 07 Month 03 Day

Last modified on

2023 Year 07 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004650


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name